Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Hidalgo, Alfredo ^a,h   Baudis, Michael ^b   Petersen, Iver ^c   Arreola, Hugo ^a   Piña, Patricia ^a   Vázquez Ortiz, Guelaguetza ^a   Hernández, Dulce ^d   González, José ^e   Lazos, Minerva ^f   López, Ricardo ^a   Pérez, Carlos ^a   García, José ^g   Vázquez, Karla ^a   Alatorre, Brenda ^a   Salcedo, Mauricio ^a  

^a Laboratorio de Oncología Genómica   (Mexico)

^b UNIVERSITY OF FLORIDA   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HOSPITAL DE ONCOLOGÍA   (Mexico)

^e Hospital de Gineco Obstetrica No 4   (Mexico)

^f HOSPITAL GENERAL DE MÉXICO   (Mexico)

^g UNIVERSIDAD LA SALLE   (Mexico)

^h SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN; INITIATION FACTOR 4E; PHOSPHOPROTEIN; RETINOL BINDING PROTEIN; RETINOL BINDING PROTEIN 1; RETINOL BINDING PROTEIN 2; STEM CELL FACTOR; UNCLASSIFIED DRUG; PRIMER DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 8P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME XQ; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MOLECULAR CLONING; PRECANCER; UTERINE CERVIX CARCINOMA; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HETEROZYGOSITY LOSS; IMAGE PROCESSING; METABOLISM; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; DNA; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOSS OF HETEROZYGOSITY; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 26844464698     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-77     Document Type: Article

References (38)

1. Walboomers J, Jacobs M, Manos M, Bosch X, Kummer A, Shah K, Snijders P, Peto J, Meijer C, Muñoz N: Human Papilloma Virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Bosch X, Muñoz N: The viral etiology of cervical cancer. Virus Res 2002, 89:183-190.
3. Münger K, Howley P: Human papillomavirus immortalization and transforming functions. Virus Res 2002, 89:213-228.
4. Ried T, Hesselmeyer K, Blegen H, Schröck E, Auer G: Genomic changes defining the genesis, progression and malignancy in solid human tumors: a phenotype/genotype correlation. Genes Chrom Cancer 1999, 25:195-204.
5. Pihan G, Wallace J, Zhou Y, Doxsey S: Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003, 63:1398-1404.
6. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C: Genetic instability and darwinian selection in tumours. Trends Cell Biol 1999, 9:M57-M60.
7. Heselmeyer K, Schröck E, Du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996, 93:479-484.
8. Heselmeyer K, Macville M, Schröck E, Blegen H, Hellström A, Shah K, Auer G, Ried T: Advanced stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chrom Cancer 1997, 19:233-240.
9. Dellas A, Torhorst J, Jiang F, Proffit J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch M, Moch H: Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma stage IB detected by comparative genomic hybridization. Cancer Res 1999, 59:3475-3479.
10. Kirchhoff M, Rose H, Petersen B, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm S, Philip J: Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chrom Cancer 1999, 24:144-150.
11. Allen D, White D, Hutchins A, Scurry J, Tabrizi S, Garland S, Armes J: Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell carvical cancer. Br J Cancer 2000, 83:1659-1663.
12. Kirchhoff M, Rose H, Petersen B, Maahr J, Gerdes T, Philip J, Lundsteen C: Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lessions. Cancer Genet Cytogenet 2001, 129:47-51.
13. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H: Comparative Genomic Hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chrom Cancer 2002, 33:98-102.
14. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, Rao PH: Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chrom Cancer 2003, 36:233-241.
15. Narayan G, Pulido HA, Koul S, Lu XY, Harris CP, Yeh YA, Vargas H, Posso H, Terry MB, Gissmann L, Schneider A, Mansukhani M, et al.: Genetic analysis identifies putative tumor supressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene 2003, 22:3489-3499.
16. Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VV: Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 2004, 4:5.
17. Solinas-Toldo S, Dürst M, Lichter P: Specific chromosomal imbalances in human papillomavirus transfected cells during progression toward immortality. Proc Natl Acad Sci USA 1997, 94:3854-3859.
18. Hidalgo A, Schewe C, Petersen S, Salcedo M, Gariglio P, Schlüns K, Dietel M, Petersen I: Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumor cell lines. Eur J Cancer 2000, 36:542-548.
19. Hidalgo A, Monroy A, Arana R, Taja L, Vázquez G, Salcedo M: Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines. BMC Cancer 2003, 3(1):8.
20. Lichter P, Joos S, Bentz M, Lampel S: Comparative genomic hybridization: uses and limitations. Semin Hematol 2000, 37:348-357.
21. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chrom Cancer 1997, 20:399-407.
22. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, et al.: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet 1998, 20:207-211.
23. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet 1999, 23:41-46.
24. Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Hugo P, Brousseau R, Hoang T: Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancer and leukemias. Cancer Res 2001, 61:6281-6289.
25. Baudis M, Cleary ML: Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001, 17:1228-1229.
26. Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A: Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2000, 6:3600-3606.
27. Kwasniewska A, Gozdzicka-Jozefiak A, Postawski K, Miturski R: Evaluation of DNA mismatch repair system in cervical dysplasias and invasive carcinomas related to HPV infection. Eur J Gynaecol Oncol 2002, 23:231-235.
28. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398:714-718.
29. Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD, Crum CP: Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001, 80:24-29.
30. Wang T, Chen B, Yang Y, Chen H, Wang Y, Cviko A, Quade B, Sun D, Yang A, Mckeon F, Crum C: Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases. Hum Pathol 2001, 32:479-486.
31. Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ: P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol 2003, 91:346-353.
32. Chen H, Toyooka S, Gazdar AF, Hsieh JT: Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem 2003, 278:3121-3130.
33. Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC, Xu XX: Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer 2002, 94:2380-2392.
34. Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu XX: Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene 2000, 19:4847-4854.
35. Huang LW, Chao SL, Chen TJ: Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis. Gynecol Oncol 2003, 90:331-337.
36. Butler D, Collins C, Mabruk M, Leader MB, Kay EW: Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Gynecol Oncol 2002, 86:144-149.
37. Takizawa S, Nakagawa S, Nakagawa K, Yasugi T, Fujii T, Kugu K, Yano T, Yoshikawa H, Taketani Y: Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer. Br J Cancer 2003, 88:1213-1216.
38. Thorland EC, Myers SL, Gostout BS, Smith DI: Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003, 22:1225-1237.